In March, the journal Nature published the discoveries of two paradigm-breaking antimicrobial compounds in as many weeks: a ...

Antimicrobial resistance (AMR) is an escalating global health threat that jeopardizes the effectiveness of existing ...

Antimicrobial-resistant bacteria of animal origin can be transmitted to humans through the environment and food products, ...

Beyond fostering resistance, common plastics like polyethylene, polypropylene and polystyrene serve as vectors for ...

A peptide with a dual mechanism of action – it dissolves the bacterial membrane and activates the immune system – could be an ...

A pro-life group has released a peer-reviewed report pushing back against what it calls a baseless claim that abortion drugs ...

Grade 12 Medicine Hat High School student Fatema Riaz dreams of leading discoveries to treat “superbugs” or bacteria that has ...

In a second piece of good news in the development of new antimicrobials this week, GSK has said it will file its oral ...

The Swiss drugmaker says the safety and efficacy of zosurabalpin will be investigated in a study involving 400 patients with ...

Debiopharm initially received funding from CARB-X in 2017 for pre-clinical development of Debio1453, which inhibits an essential fatty acid synthesis enzyme found in N gonorrhoeae and other bacteria.

Debiopharm ( a privately-owned, Swiss-based biopharmaceutical company aiming to establish tomorrow's standard-of-care to cure cancer and infectious diseases, is honored to share that ...

Scientists are probing woolly mammoth and Neanderthal genetic codes for new compounds as today’s drugs lose potency.